Transcriptomics analysis on hepatic tissue identified up-regulated IL-32 levels in NAFLD patients, as compared to liver tissue obtained from obese individuals showing no signs of hepatic steatosis. This evidence concerns the gene IL32 and metabolic dysfunction-associated steatotic liver disease.